SAN DIEGO, — Trovagene, Inc. (Pink Sheets: TROV.PK), a developer of transrenal molecular diagnostics, announced the appointment of Keith McCormick as head of commercial operations, effective April 16, 2012. McCormick brings extensive pharmaceutical and diagnostic sales, marketing and operational experience. Most recently, he served as senior director of sales operations at bioTheranostics, Inc. McCormick served […]
Jena, — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) has acquired the remaining shares in its subsidiary AJ Roboscreen GmbH and is now its sole owner with 100.0%. The Jena-based manufacturer of analytical instrumentation technology, life science instruments and optoelectronics has thus integrated another subsidiary further into the Group. “We are pursuing a very […]
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced an agreement with MultiPlan, Inc., the nation’s leading provider of healthcare cost management solutions (PHCS). Under this expanded agreement, Sequenom’s participation in the PHCS and MultiPlan networks will now include its Center for Molecular Medicine’s MaterniT21 PLUS™ laboratory-developed test to […]
SAN DIEGO,– Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has extended the term of a supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools and integrated systems for the large scale-analysis of genetic variation and function. The amendment extends the term […]
Hilden, Germany, and Germantown, Maryland, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG […]
CAMBRIDGE, Mass.– Helicos BioSciences Corporation (OTCQB: HLCS.PK) announced today that it has entered into an Asset Purchase Agreement with Sequenom, Inc. pursuant to which Sequenom purchased all rights, title and interest in Helicos’ United States Patent Application Serial Nos. 12/709,057 and 12/727,824 (Methods for Detecting Fetal Nucleic Acids and Diagnosing Fetal Abnormalities) and certain related […]
SAN DIEGO,– Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported that more than 12,700 total tests, including in excess of 4,900 MaterniT21 PLUS laboratory-developed tests (LDT) offered by Sequenom Center for Molecular Medicine (Sequenom CMM), were accessioned during the first quarter of 2012. This equates to an annualized […]
Ann Arbor, MI – Rubicon Genomics, Inc., a company developing and commercializing pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms, today announced that it has signed a supply agreement with KREATECH Diagnostics for use of Rubicon’s OmniPLEX-D whole genome amplification technology. Under the terms of the agreement, Rubicon will […]
Since February of this year Danish Ramcon A/S offers Anagnostics’ drugs of abuse testing and pharmacogenetics solutions as distribution partner. During the course of the year, further products, especially relating to severe infection testing will follow. Establishing the innovative products in the Northern European Countries as well as competent and first class customer support are […]
NEW YORK– Enzo Biochem Inc. (NYSE: ENZ) today announced the launch of the ColonSentry™ test for assessing a patient’s risk of having colorectal cancer, the first in a pipeline of new molecular diagnostic products the Company plans for the medical community. “As a pioneer in the use of genomic and genetic information as a catalyst […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
